SEER 1975–2023 analysis demonstrated a long-term mortality inflection from rising rates to sustained declines, with the ...
A Series D round led by Venrock will support an ongoing Phase 2 study, and planned Phase 3 trial, of an oral drug the biotech ...
Proceeds to support registration-enabling trials, DOMMINO-1 and DOMMINO-2, and continued development of the first-in-class p300/CBP inhibitor Financing led by Venrock Healthcare Capital Partners, with ...
A healthcare provider shares her journey with multiple myeloma, discussing the physical, emotional and financial challenges ...
Hosted on MSN
Living longer and stronger with multiple myeloma
Why it matters: Multiple myeloma is the second most common blood cancer in adults, affecting over 127,000 Americans, with survival rates steadily improving due to treatment advances. What’s changing: ...
Multiple myeloma is a type of blood cancer that starts in your bone marrow. This is the soft, spongy tissue inside your bones that makes most of your blood cells. It includes plasma cells, which help ...
The Translational Genomics Research Institute (TGen), part of City of Hope, today announced the launch of JAYseqTM, a ...
Each monthly installment examines an aspect of multiple myeloma care, including delivering the diagnosis, building trust, ...
Multiple myeloma – a rare form of blood cancer – is usually found in people 65 and older. While it’s rare in young adults, a small percentage of people 19-40 also have the disease. Only 10% of people ...
It’s important to know that at first, multiple myeloma may not cause any symptoms. Usually, it is only suspected after a routine blood test shows an abnormality. After the disease has progressed, ...
Multiple myeloma and chronic lymphocytic leukemia are both types of blood cancer that affect the white blood cells. However, important differences exist between these conditions. These differences ...
Black Americans have a higher likelihood of multiple myeloma than white Americans but face disparities in treatment. Various factors may contribute to why multiple myeloma disproportionally affects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results